Strong Impact of Acute Kidney Injury on Survival After Liver Transplantation

被引:97
作者
Zhu, M. [1 ]
Li, Y.
Xia, Q. [2 ]
Wang, S. [2 ]
Qiu, Y. [1 ]
Che, M. [1 ]
Dai, H. [1 ]
Qian, J. [1 ]
Ni, Z. [1 ]
Axelsson, J. [3 ,4 ]
Yan, Y. [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Renal, Shanghai 200127, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Transplantat, Shanghai 200127, Peoples R China
[3] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Renal Med, Stockholm, Sweden
[4] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Baxter Novum, Stockholm, Sweden
关键词
ACUTE-RENAL-FAILURE; SERUM CREATININE; DISEASE; THERAPY; IMPAIRMENT; PREDICTION;
D O I
10.1016/j.transproceed.2010.08.059
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Acute kidney injury (AKI) is a major complication in orthotopic liver transplantation (OLT). In an evaluation of Acute Kidney Injury Network (AKIN) criteria in liver transplanted patients, we retrospectively analyzed the usefulness of these criteria to predict survival of 193 consecutive patients at a single center who underwent primary OLT for clinical parameters and peak AKI. Postoperative AKI according to AKIN occurred in 60.1% of the patients, namely, stages 1, 2, and 3 in 30%, 13% and 17.1% respectively. Using multivariate logistic regression, AKIN stage 1 and 2 AM were independently associated with the pre-OLT Model for End-Stage Liver Disease (MELD) score and age, while stage 3 AKI was independently associated with MELD and Acute Physiology and Chronic Health Evaluation (APACHE) II scores. The 28-day and 1-year mortality post-OLT of AKI patients were 15.5% and 25.9% respectively compared with 0% and 3.9% among non-AM patients (P < .05 for both). The survival rates of non-AM and stages 1, 2, and 3 AM subjects were 96%, 85.5%, 84%, and 45.3%, respectively. Cox regression analysis showed independent risk factors for mortality during the first year after transplantation to include post-OLT AM (12.1; P < .05), post-OLT infection (HR 4.7; P < .01), pre-OLT hypertension (HR 4.4; P < .01) hazard ratio [HR] and post-OLT APACHE II >= 10 (HR 3.6; P < .05). We concluded that AM as defined by the AKIN criteria is a major complication of OLT linked to a poor outcomes. It remains to be evaluated whether aggressive perioperative therapy to prevent MU can improve survival among OLT patients.
引用
收藏
页码:3634 / 3638
页数:5
相关论文
共 22 条
[1]   Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group [J].
Bellomo, R ;
Ronco, C ;
Kellum, JA ;
Mehta, RL ;
Palevsky, P .
CRITICAL CARE, 2004, 8 (04) :R204-R212
[2]  
BERG CL, 2009, United States Am J T, V9, P1998
[3]   Impairment of renal function following liver transplantation [J].
Braun, N ;
Dette, S ;
Viebahn, R .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (04) :1458-1460
[4]   Risk factors of acute renal failure after liver transplantation [J].
Cabezuelo, JB ;
Ramírez, P ;
Ríos, A ;
Acosta, F ;
Torres, D ;
Sansano, T ;
Pons, JA ;
Bru, M ;
Montoya, M ;
Bueno, FS ;
Robles, R ;
Parrilla, P .
KIDNEY INTERNATIONAL, 2006, 69 (06) :1073-1080
[5]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[6]   Acute renal failure requiring renal replacement therapy after orthotopic liver transplantation [J].
Faenza, S. ;
Santoro, A. ;
Mancini, E. ;
Pareschi, S. ;
Siniscalchi, A. ;
Zanzani, C. ;
Pinna, A. D. .
TRANSPLANTATION PROCEEDINGS, 2006, 38 (04) :1141-1142
[7]   Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation [J].
Fraley, DS ;
Burr, R ;
Bernardini, J ;
Angus, D ;
Kramer, DJ ;
Johnson, JP .
KIDNEY INTERNATIONAL, 1998, 54 (02) :518-524
[8]   Immunosuppression for liver transplantation [J].
Geissler, E. K. ;
Schlitt, H. J. .
GUT, 2009, 58 (03) :452-463
[9]  
Guitard J, 2006, CLIN NEPHROL, V65, P103
[10]   A model to predict survival in patients with end-stage liver disease [J].
Kamath, PS ;
Wiesner, RH ;
Malinchoc, M ;
Kremers, W ;
Therneau, TM ;
Kosberg, CL ;
D'Amico, G ;
Dickson, ER ;
Kim, WR .
HEPATOLOGY, 2001, 33 (02) :464-470